ABCL

#1697
AbCellera Biologics Inc. - Common Shares
6.1 8 USD
+7.85%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
6.05
6.22
Rango anual
1.98
6.52
Cambio diario
+7.85%
Variación mensual
+59.28%
Variación en los últimos 6 meses
+71.19%
Cambio anual
+202.94%
Cierres anteriores
5.7 3
Open
6.0 6
Mínimo
6.0 5
High
6.2 2
Volumen
1 579
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 1.89 B
  • Employee 562
  • Founded 2012
  • CEO Carl Hansen
  • Website www.abcellera.com
  • Headquarter British Columbia, Canada
  • FIGI BBG00LLW2MF2
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-6.98
Relación precio/flujo de caja
13.6

AbCellera Biologics Inc. - Common Shares

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Noticias